ARCHIVE OF RESEARCH PUBLICATIONS 
EQUINE PHARMACOLOGY, THERAPEUTICS, AND TOXICOLOGY LABORATORY,
GLUCK EQUINE RESEARCH CENTER, UNIVERSITY OF KENTU
CKY

Search for specific topics using your web browser's search function.
   
001 Recovery of procaine from biological fluids.  Res Commun Chem Path Pharmacol.  11(2): 187-94, 1975
002 The pharmacology of procaine in the horse. I. A preliminary report.  Am J Vet Res, 37:1107-1110, 1976.
003 The pharmacology of procaine in the horse II. The procaine esterase properties of equine plasma and synovial fluid.  Am J Vet Res, 37:1165-1170, 1976.
004 The pharmacology of procaine in the horse. III. Evidence against the existence of a procaine-penicillin complex.  Am J Vet Res, 38:437-442, 1977.
005 The pharmacology of procaine in the horse: Pharmacokinetics and behavioral effects.  Am J Vet Res, 38:637-647, 1977.
006 Drug interactions in the horse. I. Effects of chloramphenicol, quinidine and oxyphenbutazone on phenylbutazone metabolism.  Am J Vet Res, 38:123-127, 1977.
007 Electron capture detection of an apomorphine-heptafluorobutyrate derivative at low picogram levels.  Res Commun Chem Path Pharmacol, 15(3):447-455, 1976.
008 Biochemical and behavioral effects of reserpine in the horse. Presented at the 2nd Equine Pharmacology Symposium, Ohio State University , Columbus , OH , 1978.
009 Drug interactions in the horse.  Effect of furosemide on plasma and urine levels of phenylbutazone. Res Comun Chem Path Pharmacol. 15(2):257-64, 1976
010 A review of the pharmacology of furosemide in the horse.  Proc 3rd Intíl Equine Doping Conference, Rome, March 1977.  Atti Della Conferenza Intíl Sul Doping, pp 323-352, 1978.
011 Gas liquid chromatography and electron capture detection in equine drug testing.  
012 Pine-oil toxicity in the horse: Drug detection, residues and pathological changes.  Res Commun Chem Path Pharmacol 15:291-301, 1976.
013 Drugs, Horses and the Kentucky Equine Drug Research Program.  Proc 2nd Conv Natn'l Assoc. State Racing Commissioners, San Diego, CA, 1976, pp 89-99.
014 Use of Bumetanide in Horses.  Letter.  Amer J Vet Res  March 1977
015 The pharmacology of procaine in the horse V. Relationships between plasma and urinary concentrations of procaine.  J Eq Med Surg, 1:188-194, 1977.
016 Phenylbutazone (Butazolidin) in horses: A review.  J Eq Med Surg, 1:221-225, 1977.
017 Furosemide (Lasix) in horses: A review.  J Eq Med Surg, 1:215-218, 1977.
018 Drug interactions in the horse. III. Effects of furosemide on urinary concentrations of glucuronide metabolites of pentazocine.  Res Commun Chem Path Pharmacol, 17;447-456, 1977.
019 Interaction of ouabain and cassaine with Na++K+-ATPase and its relationship to their inotropic actions. In: Drug Action at the Molecular Level, MacMillan Pub Co, London , 1977, pp 213-133.
020 Pharmacokinetics and behavorial effects of methylphenidate in Throughbred horses. Am J Vet Res 47(5):722-26, 
021 Furosemide (Lasixģ) in the horse: An overview.  Proc 23rd Annual Conv AAEP, Vancouver , 1977, pp 419-421.
022 The pharmacology of furosemide in the horse. I. Effects on the disposition of procaine, methylphenidate, phenylbutazone and pentazocine.  J Eq Med Surg, 1:402-409, 1978.
023 The pharmacology of furosemide in the horse. II. Its detection, pharmacokinetics and clearance from urine.  J Eq Med Surg, 2:185-194, 1978.
024 The pharmacology of furosemide in the horse. III. Its detection, pharmacokinetics and clearance from urine.  J Eq Med Surg
025 Furosemide in the horse: an overview,  23rd AAEP
026 The anabolic steroid androgen group of drugs.  J Eq Med Surg, 2:163-165, 1978.
027 The pharmacology of narcotic analgesics in the horse. I. The detection, pharmacokinetics and urinary "clearance times" of pentazocine.  J Eq Med Surg, 3(4):191-198, 1979.
028 Effects of monovalent cations on Na++K+-ATPase in rat brain slices.  Europ J Pharmacol, 55:281-292, 1979
029 A review of the pharmacology of procaine in the horse.  J Eq Med Surg, 2:209, 213-214, 1978.
030 The pharmacology of reserpine in the horse. I. Effects of reserpine and imipramine on platelet uptake of serotonin, in vitro and in vivo.  J Eq Med Surg 3(7):325-330, 1979.
031 The pharmacology of narcotic analgesics in the horse. II. Studies on the detection, pharmacokinetics, urinary clearance times and behavioral effects of pentazocine and fentanyl in the horse.  Irish Vet J, 33:169-176, 1979.
032 Narcotic analgesics and the opiate receptor in the horse.  J Eq Med Surg, 2:397-399, 1978.
033 Plasma and urinary drug concentrations, drug "clearance times", and pharmacological effects.  J Eq Med Surg, 2(6):262-267, 1978.
034 A review of the pharmacology of reserpine in the horse.  J Eq Med Surg, 2(10):433-438, 1978.
035 Chemotherapy in the horse: The penicillins.  J Eq Med Surg, 2(11):475-479, 1978.
036 A modified Folin-Denis over-spray for the detection of phenolic alkaloidal drugs.  Irish Vet J, pp 209-213, December 1978.
037 An evaluation of pre- and post-race testing and blood and urine drug testing in horses.  J Eq Med Surg, 3(2):85-90, 1979.
038 The pharmacology of narcotic analgesics in the horse. III. Characteristics of the locomotor effects of fentanyl and apomorphine.  J Eq Med Surg, 3(6):284-288, 1979.
039 The pharmacology of narcotic analgesics in the   horse. IV. Dose and time response relationships for behavioral responses to morphine, meperidine, pentazocine, anileridine, methadone, and hydromorphone.  J Eq Med Surg, 3:377-385, 1979.
040 Quantitation and selective blockade of response to narcotic analgesics in the horse.  2nd Equine Pharmacology Symposium, The Ohio State University , Columbus pp 183-188, 1978.
041 The detection, identification and basic pharmacology of furosemide in the horse.  2nd Equine Pharmacology Symposium, the Ohio State University , Columbus , pp 43-57, 1978.
042 The pharmacology of reserpine in the horse. II. Effects of reserpine on platelet serotonin uptake and behavior.  J Eq Med Surg, 3:446-451, 1979.
043 Drugs and performance testing in racing horses. Report of NASRC Veterinary Chemists Advisory Committee, March 27, 1979 . NASRC Proceedings, San Francisco, 85-106, 1979.
044 Pharmacology Review: Testing for drugs in horses.  J Eq Med Surg, 2(12):518-524, 1978.
045 Pharmacology Review: The corticosteroids.  J Eq Med Surg,  3(1):10-15, 1979.
046 Pharmacology of narcotic analgesics in the horse.  Selective blockade of narcotic-induces locomotor activity.  Am J Vet Res 42(7):16-721, 1981.
047 Pharmacology Review: Actions of central stimulant drugs in the horse. I. J Eq Med Surg, 3(2):60-66, 1979.
048 Pharmacology Review: Actions of central stimulant drugs in the horse. II. J Eq Med Surg, 3(3):102-109, 1979.
049 Pharmacology Review: Drug metabolism and elimination in the horse.  J Eq Med Surg, 3(3):150-156, 1979.
050 Pharmacology Review: A review of recent research on furosemide in the horse.  J Eq Med Surg, 2:314, 320-321, 1978.
051 Variable-interval responding in the horse: A sensitive method of quantitating effects of centrally acting drugs.  Am J Vet Res, 43(7):1143-1146, 1982.
052 Pharmacology Review: Streptomycin, gentamicin, and the amino-glycoside antibiotics.  J Eq Med Surg, 2:206-212, 1979.
053 Pharmacology Review: The non-steroidal anti-inflammatory drugs. I. Phenylbutazone. J Eq Med Surg, 3:253-258, 1979.
054 Drugs, Racehorses and the Kentucky Drug Research Program. The Blood-Horse, Vol CII(14):1453-1455, April 1976.
055 Pharmacology Review: The non-steroidal anti-inflammatory drugs. II. Equiproxin, meclofenamic acid, flunixin and others.  J Eq Med Surg, 3(7):298-392, 1979.
056 Pharmacology Review: The phenothiazine "tranquilizers."  J Eq Med Surg, 3:460-466, 1979.
057 Medication of performance horses.  In: Equine Medicine and Surgery, Am Vet Pub, Inc, Santa Barbara , CA , 1982, pp 158-172.
058 Variable interval conditioning in the horse: A sensitive measure of behavior.  Proc 3rd Intíl Symposium on Equine Medication Control, Lexington , June 1979, pp 367-379.
059 The pharmacokinetics and behavioral effects of fentanyl and other narcotic analgesics in the horse.  Proc 3rd Intíl Symposium on Equine Medication Control, Lexington , June 1979, pp 311-321.
060 An overview of the major antibiotics in equine medicine.  Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 491-502.
061 Atypical conditions for qualitative recovery of acepromazine and chlorpromazine from plasma.  J Toxic & Environmntl Hlth, 7:745-751, 1981.
062 Current Status of Drug Receptor theory with specific reference to Na/K-ATPase and opiate receptors.  Proc 2nd Symp Vet Pharm & Therap. 1980
063 Pharmacology of corticosteroid therapy in the horse.  Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 411-415.
064 The pharmacology and therapeutics of exercise-induced pulmonary hemorrhage (EIPH).  Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 435-440.
065 The pharmacology of narcotic analgesics in the horse: Quantitative detection of morphine in equine blood and urine and logit-log transformations of this data.  Am J Vet Res 42(9):1523-1530, 1981.
066 Recovery of acepromazine from equine plasma and its pharmacology in the horse. Proc 4th Intíl Symposium on Equine Medication Control, 1981. 
067 Morphine-glucuronide hydrolysis: Superiority of glucuronidase from Patella vulgata.  Clin Chem, 28(1):83-86, 1982.
068 The pharmacology of furosemide in the horse. IV. The duration of reduction of urinary concentration of drugs.  J Equine Vet Sci, 1:203-207, 1981.
069 Phenylbutazone and other drugs in horses racing under a controlled medication program.  Proc 4th Intíl Symposium on Equine Medication Control, Melbourne , Australia , May 1981, pp 68-73.
070 Furosemide, Patella vulgata  b-glucuronidase and drug analysis: Conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine.  Res Comm in Chem Pathol Pharmacol 35(1):27-41, 1982.
071 Drug "clearance times" and "detection times" in horses: A reappraisal.  J Vet Pharmacol Therap, 5:195-197, 1982.
072 Inability of goldenseal to interfere with the detection of morphine in urine.  J Equine Vet Sci, 2(1):16-19, 1981.
073 Performance testing in the horse: A review of the role of simple behavioral models in the design of performance experiments.  J Vet Pharmacol Therap, 5:105-118, 1982.
074 Pharmacology, pharmacokinetics, and behavioral effects of acepromazine in the horse.  Proc 4th Intíl Conf Control Drugs in Racehorses, Melbourne , Australia , May 1981, pp 81-86.
075 Drugs and the Performance Horse.  Charles C. Thomas, Springfield , IL , 1981.
076 Pharmacokinetics and protein binding of morphine in horses.  Am J Vet Res, 44(5):870-874, 1983.
077 Some reflections on positive results from medication control tests in the USA.  Eq Vet J, 16:43-46, 1984.
078 The pharmacokinetics, pharmacological responses, and behavioral effects of acepromazine in the horse.  J Vet Pharmacol Therap, 5:21-31, 1982.
079 The effects of naloxone on endotoxic and hemorrhagic shock in horses.  Res Commun Chem Path Pharmacol, 44(2):227-238, 1984.
080 Effects of enkephalins versus opiates on locomotor activity of the horse.  Res Commun Chem Path Pharmacol, 35(3):405-419, 1982.
081 The pharmacology of non-steroidal anti-inflammatory drugs in the horse.  III. Flunixin meglumine (Banamineģ).  Equine Practice, 4(10):16-23, 1982.
082 Pre-race testing and its role in equine medication control.  Equine Vet J, 15(1):54-55, 1983.
083 Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horse.  Am J Vet Res, 44(1):57-63, 1983.
084 The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.  J Drug Metab Disp, 11(3):226-231, 1983.
085 Toxicoses commonly observed in horses.  In Toxicology. Current Therapy in Equine Medicine.  Sanders, Philadelphia, 1983, pp 573-615.
086 Drugs and equine performance: A review.  In Snow DH, Persson SGB, Rose RJ (eds): Equine Exercise Physiology, Proc 1st Intíl Conf, Oxford , UK , 1982, pp 510-520.
087 Effect of urine pH on urine levels of oxyphenbutazone in racing horses.  J Drug Metab Dist, 11(6):617-619, 1983.
088 Phenylbutazone: Its actions, effects, and role in equine medicine.  Modern Equine Practice, Jan/Feb 1983, p 25.
089 Pain perception in the horse and its control by medication: An overview.  Proc 5th Intíl Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 50-51.
090 Pain: Neurophysiology and experimental equine models.  Proc 5th Intíl Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 52-55.
091 Phenylbutazone: Lack of effect on normal cutaneous pain perception in the horse.  Proc 5th Intíl Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 85-89.
092 The pharmacokinetics and blood levels of furosemide after intravenous administration.  Proc 5th Intíl Conf, Cont use of drugs in race horses, Toronto , Canada , June 1983, pp 41-49.
093 Effect of urine pH on urine levels of phenylbutazone, oxyphenbutazone and g-hydroxyphenylbutazone in racing horses.  Proc 5th Intíl Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 26-33.
094 Clearance times and behavioral effects of clenbuterol in the horse.  Proc 5th Intíl Conf, Cont use of drugs in race horses, Toronto , Canada , June 1983, pp 265-271.
095 Tobin's Testimony on phenylbutazone and furosemide testing before the house subcommittee on criminal justice.  The Horsemen's Journal, 34(7):142-149, 1983.
096 Population distributions of phenylbutazone and oxyphenbutazone after oral and IV dosing in horses.  J Vet Phar Therap, 7:265-276, 1984.
097 Efficacy of testing for illegal medication in horses: A survey.  JAVMA, 187:927-930, 1985.
098 Differential effects of phenylbutazone and local anesthetics on nociception in the equine.  Eur J Pharm, 107:35-41, 1985.
099 Phenylbutazone and its metabolites in plasma and urine of Thoroughbred horses racing in California and Kentucky: Population distributions and the effects of urinary pH.  J Vet Pharm Therap, 8:136-149,1985.
100 Drugs and race-horse performance.  Trends in Pharm Sci, 6(3):129-132, 1985.
101 Effects of phenylbutazone and oxypenylbutazone on basic drug detection in high performance TLC systems. J Vet Pharmacol Therap  8:181-89, 1985
102 Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after various dosage regimens.  Am J Vet Res, 46(4):932-938, 1985.
103 Phenylbutazone levels in post-race samples from horses racing in Kentucky: A review.  Proc 4th Symposium on Veterinary Pharmacology and Therapeutics, College Station TX, April 1984, pp 96-115.
104 A method for studying cutaneous pain perception and analgesia in horses.  J Pharm Meth, 13(3):267-274, 1985.
105  Phenylbutazone in the horse: A review.  J Vet Pharmacol Therap, 9:1-25, 1986.
106 Dose-related effects of fentanyl on autonomic and behavioral responses in performance horses.  Gen Pharmacol, 16(3):253-258, 1985.
107 Dose-related effects of ethylketazocine on nociception, behavior, and autonomic responses in the horse.  J Pharm Pharmacol, 38(1):40-45, 1986.
108 Effects of phenylbutazone and oxypenylbutazone on acicic drug detection in high performance TLC systems. Journal of Pharmaceutical Methods T6:297-313, 1986
109 Quantification of equine hoof lameness using an electronic hoof tester.  Proc 6th Intíl Conf Racing Analysts Vets. Hong Kong, 1985, pp 325-329.
110 The effects of kappa-opioid receptor narcotics in the horse: A new class of equine analgesics.  6th Intíl Conf Racing Analysts Vets. Hong Kong, 1985, pp 37-45.
111 Testing for drugs in horses. J Eq Vet Sci, 6(2):93-97, 1986.
112 Radioimmunoassay screening for etorphine in racing horses.  Res Commun Chem Path Pharmacol, 52(2):237-249, 1986.
113 Radioimmunoassay screening for etorphine in racing horses.  Crone DL (ed) Proc 6th Intíl Conf Racing Analysts Vets., Hong Kong, 1985, pp 199-203.
114 Experiences as an expert witness: Educating people while under oath.  J Eq Vet Sci, 6(3):129-133, 1986.
115 Efficacy and cost of testing for illegal medications in horses.  Proc 6th Intíl Conf Racing Analysts and Vets. Hong Kong, 1985, pp 113-121.
116 Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.  Proc 6th Intíl Conf Racing Analysts and Vets. Hong Kong, 1985
117 Influence of urinary pH on concentrations of phenylbutazone and its metabolites in post-race urine samples.  Crone DL (Ed) Proc 6th Intíl Conf Racing Analysts and Vets. Hong Kong, 1985, pp 59-68.
118 Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.  Proc 6th Intíl Conf Racing Analysts and Vets. Hong Kong, 1985, pp 83-88.
119 Medication Control: Uncertainty in the "Detection Times" for drugs in horses.  J Eq Vet Sci 6(3):124-128, 1986.
120 Medication Control: Rules.  J Eq Vet Sci 6(4):191-195, 1986.
121 Medication Control: The efficacy and cost of drug testing.  Pharmacology 6(6):333-36
122 TLC detection of etorphine in equine urines.  Crone DL (ed) Proc 6th Intíl Conf Racing Analysts and Vets, Hong Kong, 1985, pp 205-208.
123 High-sensitivity radioimmunoassay screening method for fentanyl.  Am J Vet Res 47(10):2180-2183, 1986.
124 Pre-purchase testing for drugs in horses: A review.  J Eq Vet Sci, 6(1):35-39, 1986.
125 Dose related effects of kappa agonist U-50,488H on behavior, nociception and autonomic response in the horse. Eq Vet J, 20(2):114-118,1988.
126 Radioimmunoassay screening for fentanyl in equine and human urine samples with an iodinated fentanyl analog.  Proc 40th Meeting Assoc of Racing Chem, Lexington, KY, 141-150, 1986.
127 Narcotic analgesics, their detection and pain measurement in the horse: A review. Eq Vet J, 21(1):4-12, 1989.
128A Drugs and performance, part 1.  In Equine Sports Medicine, Lea and Febiger, Philadelphia, 1988. pp189-204  
128B Drugs and performance, part 2.
129 Hordenine: Pharmacology, pharmacokinetics and behavioural effects in the horse. Eq Vet J, 22(6):437-441, 1990.
130 Significance of Procaine residues in post race urine samples.  Proc 41st Convent Am Assoc. Equine Pract, pp 168-169, 1995.
131 Radioimmunoassay for etorphine in horses with a 125I analog of etorphine.  Am J Vet Res, 49(5):622-628, 1988.
132 Detomidine: A preliminary analysis of its duration of action in the horse by variable interval responding.  Eq Vet J, 20(5):320-322, 1988.
133 Pharmacologic effects and detection methods of methylated analogs of fentanyl in horses.  Am J Vet Res 50(4):502-07
134 A review of the pharmacology and detection of fentanyl and its congeners in the horse.  Proc 41st Meeting Assoc of Racing Chem., 1987, Los Angeles, CA, pp287-313.
135 The pharmacology, pharmacokinetics, and behavioral effects of diisopropylamine dichloroacetate (DADA) in the horse: A preliminary report.  Gen Pharmacol, 19(5):683-688, 1988.
136 Immunoassay detection of drugs in horses. I. Particle concentration fluoroimmunoassay detection of fentanyl and its congeners.  Res Commun Chem Path Pharmacol, 57(3):389-407, 1987.
137 Immunoassay detection of drugs in horses. II. Detection of carfentanil in equine urine by RIA, PCFIA and ELISA.   Res Commun Subst Abuse, 8(2):59-75, 1987.
138 Immunoassay detection of drugs in horses.  III. Detection of morphine in equine blood by a one step ELISA assay.  Res Commun Chem Path Pharmacol, 59(2):259-278, 1988.
139 Population parameters of equine urine pH and methods of acidification.  Proc 7th Intíl Confer Racing Analysts Vets, Louisville, KY, April 1988, 259-265.
140 Immunoassay detection of drugs in horses. IV. Detection of fentanyl in equine blood and urine by a one step ELISA assay.  Res Comm Chem Path Pharmacol, 60(1):97-115, 1988.
141 Immunoassay detection of drugs in racing horses. V. Detection of mazindol in equine blood and urine by a one step ELISA assay. Res Comm Subst Abuse, 9(1):13-30, 1988. 
142 Operant conditioning and its applications in equine pharmacology.  J Equine Vet Sci, 9(3): 124-130, 1989.
143 Immunoassay detection of drugs in racing horses. VI.  Detection of furosemide (Lasixģ) equine blood by a one step ELISA and PCFIA.  Res Comm Chem Path Pharmacol, 61(1): 111-128, 1988.
144 Immunoassay detection of drugs in racing horses. VII. Detection of acepromazine in equine blood and urine by ELISA and PCFIA.  Res Comm Chem Path Pharmacol, 61(3):391-412, 1988.
145 Screening for human drugs of abuse by particle concentration fluorescence immunoassay (PCFIA).  Res Comm Subst Abuse, 9(3,4):129-155, 1988.
146 The detection of furosemide in equine blood by fluorescence and enzyme-linked immunoassays.  Proc 7th Intíl Confer Racing Analysts Vets, Louisville, KY, April 1988, 113-122.
147 Enzyme linked immunosorbent assay (ELISA): A revolution in equine drug testing. Equine Veterinary Data, 9(2):19-31, 1988.
148 Detection of fentanyl and fentanyl derivatives using RIA and ELISA
149 ELISA detection of morphine in the horse.  Proc 7th Intíl Confer Racing Analysts Vets, Louisville, KY, April 1988, 145-153.
150 ELISA detection of acepromazine in the horse.  Proc 7th Intíl Confer Racing Analysts Vets, Louisville, KY, April 1988, 155-160.
151 Medication Control: The efficacy and cost of drug testing. J Eq Vet Sci 6(6):333-336, 1986.
152 Immunoassay detection of drugs in racing horses.  VIII. Detection of cocaine in equine blood and urine by particle concentration fluorescence immunoassay.  Res Comm Subst Abuse, 10(1):1-14, 1989.
153 Immunoassay detection of drugs in racing horses. IX. Detection of detomidine in equine blood and urine by radioimmunoassay.  Res Comm Chem Path Pharm, 63(2):263-279, 1989.
154 Immunoassay detection of drugs in racing horses. X. Detection of phenylbutazone in equine blood and urine by particle concentration fluoroimmunoassay. Res Comm Subst Abuse, 10(2):123-139, 1989.
155 Immunoassay detection of drugs in biological samples:  XI. ELISA and RIA detection of fentanyl, alfentanil, sufentanil and carfentanil in equine blood and urine.  Res Comm Chem Pathol Pharmacol, 63(1):129-152, 1989.
156 Non-isotopic immunoassay drug tests in racing horses: A review of their application to pre-and post-race testing, drug quantitation, and human drug testing.  Res Comm Chem Path Pharm, 62(3):371-395, 1988.
157 A synthesis of N-substituted beta-alanines: Michael addition of amines to trimethylsilylacrylate.  Synthesis, 946-949, 1989.
158 Immunoassay detection of drugs in racing horses:  Detection of ethacrynic acid and bumetanide in equine urine by ELISA.  J Analytical Tox, 18: 95-100, 1994.
159 The effects of drugs on race horse performance. Proc 34th Convent Am Assoc. Equine Pract, San Diego, CA, Dec, 1988, pp 639-650.
160 Immunoassay based pre-race testing:  An effective pre-race testing system. In: Breccia A (ed), Il Controllo Antidoping dei Cavalli da Corsa (Proc Intíl Seminar Tech Pharmacol Legal Aspects Antidoping Control Racehorses).  Bologna, Italy, October, 1988, pp 43-52 (145-157).
161 ELISA based immunoassay tests in post-race testing. In: Breccia A (ed), Il Controllo Antidoping dei Cavalli da Corsa (Proc Int'l Seminar Tech Pharmacol Legal Aspects Antidoping Control Racehorses). Bologna, Italy, October, 1988, pp 85-104 (163-184).
162 ELISA testing: backgrounds in equine urine, test sensitivity, sample pooling and significance of number of tests.  Proc 45th Meeting Assoc Official Racing Chem 308-326, 1992.
163A Steroidal anti-inflammatory agents and adrenocorticotropic hormones.  Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp.  23-30, 1989.
163B Detection times and clearance times for drugs in racing horses. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 31-37, 1991.
163C Medication for exercised-induced pulmonary haemorrhage and its effects on other medications. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 43-47, 1991.
163D Narcotics and stimulants: How they affect horses. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 25-31, 1991.
163E Steroidal anti-inflammatory agents and adrenocorticotropic hormone. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 19-25, 1991.
163F Tranquilizers, analgesics and local anaesthetics. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 47-59, 1991
164 Medication for exercise-induced pulmonary hemorrhage (EIPH) and its effects on other medications.  Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 134-141, 1989.
165 Detection times and clearance times for drugs in racing horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp.  105-113, 1989.
166 Non-steroidal anti-inflammatory drugs: Phenylbutazone and others.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 13-19, 1991.
167 Pre- and post-race testing for drugs in racing horses.  (Lecture Presentation, Paper from Bain Fallon Lectures)  Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 37-43, 1991.
168 Tranquilizers, analgesics and local anesthetics.  Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 179-187, 1989.
169 Anabolic steroids: use and excretion data. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 150-157, 1989.
170 Narcotics and stimulants: how they affect horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 49-59,1989.
171 The effects of drugs on equine performance and the use of ELISA tests in equine medication control. [Presented to World Equine Vet Assoc. (Equitana), Essen, West Germany, 1989.]  J Eq Vet Sci, 9 (3): 160-168, 1989.
172 Evaluation of threshold doses of drug action in the horse using hematocrit values as an indicator.  Res. Comm. Chem. Path. Pharmacol, 75(2):231-241, 1992.
173 Morphine and etorphine:  Detection by ELISA in equine urine.  J Analytical Tox, 15(6):305-310, 1991.
174 Number of negative tests required to exclude specific levels of agent abuse in equine forensic chemistry.  Submitted to Equine Practice, 1995.
175 Clearance times and the forensic significance of the dietary anthelmintic pyrantel tartrate in performance horses.  J Eq Vet Sci., 11(4):220-224, 1991.
176 Immunoassay detection of drugs in racing horses.  XIX. Detection of benzoylecgonine(BZE)/cocaine in equine urine by ELISA.  Proc 44th Meeting Assoc. Official Racing Chem, Cincinnati, OH, pp. 218-228, 1991.
177 Development and characterization of an ELISA for cotinine in biological fluids.  Inhalation Toxicology, 5(4): 403-413, 1993.
178 Identification of metabolites of azaperone in horse urine, J Pharm Sci. 85 pp 79-84, 1996.
179 The dietary anthelmintic pyrantel tartrate: An analysis of its detection times in geldings, mares and stallions.  Short CR (ed) Proc 9th Intíl Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 321-326.
180 228. Stanley SD, Yang J-M, Wood TW, Selonen JS, Watt DS, Tai H-H, Tobin T:  Detomidine clearance in the horse as determined by ELISA.  Short CR (ed) Proc 9th Intíl Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 193-201.
181 ELISA detection of azaperone in the racehorse.  Short CR (ed) Proc 9th Intíl Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 187-192.
182 Development of an ELISA for procaine in racing horses and dogs. Short CR (ed) Proc 9th Intíl Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 377-384.
183 The development and characterization of an ELISA for trans-3'-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. Bengston DA, Henshel DS (eds), Environmental Toxicology and Risk Assessment: Biomarkers and Risk Assessment (5th Vol), Am Soc Testing Materials, Philadelphia, 1996, pp 149-162. [KY Ag Exp Sta #92-4-167]
184 Exercise-induced pulmonary hemorrhage (EIPH)  findings, Proc of Workshop, Part I.  Equine Pract, 14(1):19-25, 1992.
185 Clinical use and characteristics of the corticosteroids.  Vet Clin N Amer:  Equine Practice, Drug Use in Performance Horses, Vol 9, Saunders, Philadelphia, 1993, pp 543-562.
186 A  review of the Pharmacology, pharmacokinetics, and regulatory control in the US of local anesthetics in the horse.  J Vet Pharmacol Therap, 18: pp 397-406, 1995.
187 Exercise-induced pulmonary hemorrhage (EIPH) findings, Proc of Workshop, Part II.  Equine Pract, 14(2):9-15, 1992.
188 Exercise-induced pulmonary hemorrhage EIPH) findings, Proc of Workshop, Part III.  Equine Pract, 14(3):28-31, 1992.
189 Determination of highest no-effect doses (HNEDs) for the local anesthetic responses to procaine, cocaine, bupivacaine and benzocaine. Equine Vet J, 28:30-37, 1996.
190 Determination of the local anesthetic efficacy of procaine, cocaine, bupivacaine and benzocaine.  Proc 10th Intíl Conf Racing Analysts Vets, Stockholm, Sweden, p. 303-306, 1994.
191 Equine Drugs and Vaccines:  A Guide for Owners and Trainers.  Breakthrough Press, Ossining, NY, 1994, 336 pp.
192 ELISA and RIA detection of fentanyl in the horse. Proc 7th Intíl Confer Racing Analysts Vets, Louisville, KY, April 1988, 123-133.
193 A review of the methodologies used to determine the highest no-effect doses (HNEDs) for medications in horses.  Proc Testing Therap Med Environ Diet Subst Racing Horses, Lexington, KY, 1995, pp 169-174.
194 Pre- and post-race testing for drugs in racing horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 115-124, 1989.
195 Character and duration of pharmacological effect of isoxsuprine.  Proc 41st Convent Am Assoc. Equine Pract, pp 166-167, 1995.
196 Racing horses, nitroglycerin and exercise-induced pulmonary hemorrhage.  Equine Vet J, 27(4):240-241, 1995.
197 Regulatory significance of procaine residue in plasma and urine samples:  Preliminary communication, Equine Vet J, 28(2), 121-125, 1996.
198 Thresholds for high potency drugs:  Plasma or urinary thresholds?  Proc Testing Therap Med Environ Diet Subst Racing Horses, Lexington, KY, 1995, pp 185-189.
199 Frequency distribution of post-race urine pH from thoroughbreds and standardbreds:  Research and regulatory significance.  Equine Vet J, 27:471-473, 1995.
200 Interim report on the workshop:  Testing for Therapeutic Medications, Environmental and Dietary Substances in Racing Horses, Univ of Kentucky, Lexington, KY, 1994.
201 Testing for drugs, medications and other substances in racing horses.  Proc for the Short Course: Recent Advances in Equine Nutrition, Kentucky Equine Research, Inc., Versailles, KY, 1995, pp 1-26.  [KY Ag Exp Sta #95-14-057]
202 Fifties rules, nineties testing:  The need for thresholds for therapeutic medications.  Racing Update, 18 (10):89-92, 1995.
203 Development of a mass spectral confirmation scheme for the carboxylic acid metabolites of detomidine and medetomidine in horse urine. Submitted to Analytical Toxicology, 1992.
204 Exercise-induced pulmonary hemorrhage (EIPH): A Review of the etiology and pathogenesis.  Equine Pract., 19 (1):  22-28, 1997. [KY Ag Exp Sta # 95-14-182]
205 Effect of a-phenyl-tert-butylnitrone on endotoxin toxemia in horses.  Vet Human Toxicol 39 (5) October 1997:  pp 268-271. [KY Ag Exp Sta #95-14-077]
206 Equine Drug Testing: How it works, National HBPA Medication Guide, pp. 42-51, 1998.  KY Ag. Exp. Sta. #9814-26 
207 The effects of steroids in racing horses. Pacemaker Update International, 2: 48, 1989.
208 An Overview of Dietary, Environmental, and Endogenous Substances of Regulatory Concern in Racing Horses.  AAEP Proceedings  41:156-59, 1985
209 Amantadine and equine influenza:  Pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J, 29(2): 104-110, 1997. [KY Ag Exp Sta #95-14-134]
210 Immobilization of domestic goats (Captra hircus) using orally administered carfentanil citrate and detomidine HCL.  J Zoo Wildlife Med, 28 (2):  158-165, 1997.
211 An overview of the methylxanthines and their regulation in the horse.  Equine Practice, 20(1):10-16, 1998.  [KY Ag Exp Sta #96-14-084].
212 Dietary, environmental, and endogenous substances in horses. In Medication Reference Guide, National Horsemenís Benevolent & Protective Association, pp 52-58, 1998.
213 Lack of  local anesthetic efficacy of Sarapin in an abaxial sesamoid block model. J Vet Pharmacol Therap 20, 229-232, 1997.
214 Trace Level Benzoylecgonine (BZE) Identifications in Post-Race Urines: Probable Sources and the Regulatory Significance of Such Identifications.  AAEP Proceedings  52:231-36, 2006
215 Character and duration of pharmacologic effects of intravenous isoxsuprine.  Equine Vet J, 28(4):320-326, 1996.
216 ELISA assay for caffeine. Proc 11th Intl'n Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 478-480.
217 Quantitation of the locomotor effect of therapeutic medication in a behavior chamber.  Proc 11th Intl'n Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 117-120.
218 Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res, 60:888-894, 1999. [KY Ag Exp Sta #96-14-131].
219 ELISA assay for flunixin. Proc 11th Intíl Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 466-469.
220 ELISA assay for methocarbamol. Proc 11th Intíl Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp.459-462.
221 Frequency distributions of pH values in post-race urine samples from Standardbred and Thoroughbred horses. Proc 11th Intíl Conf  Racing Analysts Vets, Brisbane, Australia, 1996, pp 442-444.
222 Passing the test: Immunoassay tests proving fast, reliable in detecting equine drugging. Horseman and Fair World, 9, 52-54, 1989.
223 Response to a survey among international racing authorities on therapeutic medications, environmental and dietary substances in racehorses. Proc 11th Intíl Conf Racing Analysts Vets, Brisbane, Australia,1996, pp 46-55.
224 Development and characterization of an equine behavior chamber and the effects of amitraz and detomidine on spontaneous locomotor activity. J Vet Pharmacol Therap, 20:396-401, 1997.
225 Absence of detectable pharmacological effects after oral administration of isoxsuprine. Equine Vet J 30(4):294-299, 1998. [KY Ag Exp Sta #96-14-142].
226 Poisonous plants and feed related poisoning in horses. The Veterinarianís Practical Reference to Equine Nutrition, 135-165, 1997.
227 Chemotherapy for equine influenza: Overview of the pharmacology and side effects of amantadine and rimantadine in the horse.  Proc 11th Intíl Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 355-357.
228 Lidocaine in the horse:  Its pharmacological effects and their relationship to analytical findings.  J Vet Pharmacol Therap 21:462-476, 1998.
229 Mepivacaine:  Its pharmacological effects and their relationship to analytical finding in the horse.  J. Vet. Pharmacol. Therap, 22:107-121, 1999. [KY Ag Exp Sta #98-14-148].
230 Ropivacaine in the horse:  Its pharmacological responses, urinary detection and mass spectral confirmation.  J Vet Pharm Therap, 24:89-98, 2001. [KY Ag. Exp. Sta #98-14-153].
231 Characterization of the antinociceptive and sedative effect of amitraz in horses.  J Vet Pharmacol Therap, 21(5):400-405, 1997. [KY Ag Exp Sta #97-14-137].
232 Medication control from 1900 to the Present.  HBPA Medication Booklet, 1998, pp. 23-29. [KY Ag Exp Sta #97-14-138].
233 Review of a consequence of highly sensitive drug testing:  The need for data on analytical-pharmacological relationships for therapeutic medication.  Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp 215-219.
234 Bupivacaine in the horse: Relationship of local anaesthetic responses and urinary concentrations of 3-hydroxybupivacaine. J Vet Pharmacol Therap, 22:181-195, 1999. [KY Ag Exp Sta #98-14-166]
235 Effects of caffeine on locomotor activity of horses: Determination of the no-effect threshold. J Applied Toxicol, 21:229-234, 2001.
236 Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation. J Vet Pharmacol Therap, 24:89-98, 2001.
237 Detection and quantitation of 3-hydroxymepivacaine in horse urine.  Proc 12th Intlín Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp324-328. [KY Ag Exp Sta #98-14-35].
238 The development of a generic fentanyl ELISA test. Proc 43rd Meeting Assoc. Official Racing Chem, 87, 1990.
239 Detection and quantitation of 3-hydroxybupivacaine in horse urine.  Proc 12th Intlín Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp287-291. [KY Ag Exp Sta #98-14-48]
240 Detection, quantification and preliminary pharmacokinetics of diclazuril in the horse.  Proc 12th Intíl Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp240-244. [KY Ag Exp Sta #98-14-39].
241 Interim report on workshop on equine protozoal myeloencephalitis:  Testing and treatment.  Manuscript distributed to workshop participants, 1998. [KY Ag Exp Sta #98-14-42].
242 Diclazuril in the horse: Its identification, detection and preliminary pharmacokinetics. J Vet Pharm Therap, 22:374-379, 1999. [KY Ag Exp. Sta #98-14-70].
243 Inter-laboratory comparison of phenylbutazone quantification
244 Testing for therapeutic medications: Analytical/pharmacological relationships and the need for ďlimitationsĒ on the sensitivity of testing for certain agents.  J Vet Pharm Therap, 22:220-233. 1999. [KY Ag Exp Sta #98-14-134].
245 Lack of local efficacy of fentanyl in the abaxial sesamoid block model.   J Vet Pharm Therap, 22:52-55, 1999 [KY Ag Exp Sta #98-14-85].
246 Pharmacokinetics and bioavailability of amantadine in the horse.  Proc 41st Convent Am Assoc. Equine Pract, Lexington, KY, 1995, pp270-271.
247 Determination of Highest No-Effect Doses (HNEDs) for local anesthetics.  Proc 41st Convent Am Assoc. Equine Pract, pp 163-165, 1995.
248 Diclazuril and Equine Protozoal Myeloencephalitis.   AAEP Proceedings 43:13-14, 1997
249 Preliminary pharmacokinetics of diclazuril and toltrazuril in the horse.  Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp15-16.
250 Development of an equine behavior chamber and effects of amitraz, detomidine and acepromazine on spontaneous locomotor activity. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp227-228.
251 Therapeutic efficacy of rimantadine HCl in experimentally induced influenza: An illness in horses. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp390-391.
252 Equine Drug Metabolites and Standards, 1997
253 Pyrilamine in the horse I. Isolation, identification and synthesis of it major urinary metabolite.
254 Diclazuril and equine protozoal myeloencephalitis.  Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp13-14.
255 Identification of hydroxyropivacaine glucuronide in equine urine by ESI+/MS/MS.  Can J Vet Res, 64(3):178-183. [KY Ag. Exp. Sta#98-14-151].
256 The regulation of drugs and medicines in horse racing in the United States.  The Association of Racing Commissioners International Uniform Classification of Foreign Substances Guide.  J Vet Pharm Therap. 21, 144-153, 1998.
257 Kentucky Laboratory takes lead against horse dopers.  Clin Chem News, 18, pages 1-11, 1992.
258 Diagnosing equine protozoal myeloencephalitisó complicating factors
259 An interim report on the Testing Integrity Program seminar ďFurosemide in the Horse:  Its Actions, Effects and Regulatory ControlĒ.  The New Orleans Hilton, Riverside, CA, March, 1998.
260 Direct MS-MS identification of isoxsuprine-glucuronide in post-adminstration equine urine.  Can J Vet Res, 64:112-116, 2000. [KY Ag. Exp. Sta #99-14-3]
261 Identification of lidocaine and its metabolites in post-administration equine urine by ELISA and MS-MS. J Vet Pharm Therap, 23:215-222, 2000. [KY Ag. Exp. Sta #00-14-91]
262 An Overview of the Scientific Methods. Booklet Published by Gluck Equine Research Center, Lexington, KY, 1998. [KY Ag. Exp. Sta #98-14-192]
263 A GC/MS method for the determination of isoxsupri≠ne in biological fluids of the horse utilizing electron impact ionization. Manuscript submitted to J Anal Tox, 2003.
264 Procedures and quality assurance aspects of the Testing Integrity Program. Submitted to Proceedings of the 52nd Meeting of the Association of Official Racing Chemists, New Orleans, LA, 1999. [KY Ag. Exp. Sta #99-14-27]
265 Immunoassay detection of drugs in racing horses. Detection of reserpine in equine blood and urine by a one step ELISA. Submitted to Fun App Tox, 1990.
266 Further characterization of equine isoxsuprine metabolites by electrospray ionization tandem mass spectrometry.  Manuscript in preparation, 2003.
267 Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA.  Braz J Med Biol Res, 34:821-824, 2001. [KY Ag Exp Sta #01-14-116]
268 Intratracheal clenbuterol in the horse: Its pharmacological efficacy and analytical detection.  J Vet Pharmacol Therap, 23:251-260, 2000. [KY Ag. Exp. Sta #99-14-167]
269 Toltrazuril Sulfone Sodium Salt: Synthesis, Analytical Detection, and Pharmacokinetics in the Horse J Vet Pharmacol Ther 2011 Kentucky Ag Expt Station Number 11-14-046
270 Remifentanil in the horse: Identification and detection of its major urinary metabolite. J Analytical Toxicol, 24:309-315, 2000. [KY Ag. Exp. Sta #99-07-145]
271 Serum concentratins and effects of detomidine delivered orally to horses in three different mediums. Vet Anaesthesia and Analgesia, 29:219-222, 2002. [KY Ag Exp Sta #02-14-018]
272 Pyrilamine in the horse: II. Detection and pharmacokinetics of pyrilamine and its major urinary metabolite. Manuscript in preparation, 2001.
273 Influence of electro-acupuncture on pain threshold in horses and its mode of action. Submitted to J Am Vet Med Assoc, 1999. [KY Ag. Exp. Sta # 99-14-170]
274 Clenbuterol in the horse: Urinary concentrations determined by ELISA and GC/MS after clinical doses. J Vet Pharmacol Therap, 24:7-14, 2001. [KY Ag. Exp. Sta #00-14-49]
275 Clenbuterol in the horse: Confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J Analyt Toxicol, 25:280-287, 2001. [KY Ag. Exp. Sta #00-14-122]
276 Detection and disposition of pyrilamine and its metabolite O-desmethylpyrilamine in equine blood and urine: A preliminary report. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp472-477. [KY Ag. Exp. Sta # 00-14-85]
277 Celecoxib in the horse: Its recovery, mass spectrometric identification, disposition and major urinary metabolites. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp162-170. [KY Ag. Exp. Sta #00-14-101]
278 A review of Association of Racing Commissioners International class 1, 2 and 3 medication violations and penalties for 1995-1999 in North America. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp303-309.
279 The postural signature device: A non-invasive tool for identifying medication thresholds. A preliminary report. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp46-52. [KY Ag. Exp. Sta #00-14-110]
280 Identification and detection of the major equine urinary metabolite of remifentanil. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp465-471. [KY Ag. Exp. Sta #00-14-104]
281 A highly sensitive LC/MS/MS detection method for clenbuterol in equine serum. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp420-426. [KY Ag. Exp. Sta #00-14-103]
282 A liquid chromatographic-electrospray tandem MS/MS method for quantitation of equine cocaine metabolites. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp413-419. [KY Ag. Exp. Sta #00-14-105]
283 Fentanyl group ELISA for the detection of remifentanil and other narcotic analgesics. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp337-340.
284 Synthesis and characterization of deuterated clenbuterol and two equine metabolites. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, 427-429. [KY Ag. Exp. Sta #01-14-8]
285 Comparison of specific gravity and osmolality in post-race urine of furosemide-treated and control Thoroughbred horses. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp345-349.
286 ELISA testing in race horses. Proc. Unione Nazionale L'Incremento Delle Razze Equine. Rome Italy, 1990.
287 ĎNo-effect limitsí: An overview and a pharmacological approach. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp36-42. [KY Ag. Exp. Sta #00-14-198]
288 ELISA assay for stanozolol. Proc 13th Intíl Conf Racing Analysts Vets, Cambridge, UK, 2000, pp341-344.
289 The detection and biotransformation of guanabenz in horses: A preliminary report. Vet Ther, 4(2): 197-209, 2003. [KY Ag. Exp. Sta. #01-14-113]
290 Guanabenz in the horse: Clinical effects and its comparison with other a2 agonists. Manuscript in preparation, 2003.
291 Equine urine pH: Normal population distribution and methods of acidification. Eq Vet J, 22(2):118-121, 1990.
292 Detection, quantification, metabolism and behavioral effects of selegiline in the horse. Veterinary Therapeutics, 4(3):257-268, 2003. [KY Ag. Exp. Sta. #01-14-186]
293 Clinical use and characteristics of the corticosteroids. Vet Clin N Amer: Equine Practice, Drug Use in Performance Horses, Vol 9, Saunders, Philadelphia, 1993, pp 543-562
294A New Therapeutic Approaches for Equine Protozoal Myelitis: Synthesis and Pharmacokinetics of Diclazuril Sodium Salt in the Horse: Proceedings of the 15th International Conference of Racing Analysts and Veterinarians, Dubai, pp 135-140
294B New Therapeutic Approaches for Equine Protozoal Myeloenchephalitis: Pharmacokinetics of Diclazuril Sodium Salts in Horses.  Veterinary Therapeutics 7(1):52-64.
295 Apparent ELISA detection times for albuterol after administration with the Torpex equine inhaler device. Vet Ther 3(3):297-307, 2002. [KY Ag Exp Sta #02-14-30]
296 Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry. J Mass Spec, 39(11):1275-862003. [KY Ag Exp Sta #02-14-60]
297 Albuterol by Torpexô and apparent ELISA ďdetection timesĒ: A preliminary report. In press, Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
298 Analytical detection and ďnormalĒ population data of cyanide and thiocyanate in equine blood and serum.  Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-168]
299 Pharmacodynamics of guanabenz and related α"2 agonists. Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002. [Abstract only]
300 Proposed methodology for the detection of Oxyglobinģ in equine plasma. Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-169]
301 Detection, quantification and pharmacokinetics of furosemide in horses: a preliminary report. In press, Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002. [Ky Ag Exp Sta #03-14-070]
302 Diclazuril and equine protozoal myeloencephalitis (EPM)--a clinical report.  Equine Vet. Education, 2:258-263, 2000 [KY Ag Exp Sta #98-14-159].
303 Stallion influence on reproductive loss during Mare Reproductive Loss Syndrome (MRLS) in Lexington, Kentucky 2001. Abstract submitted to Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
304 The effect of intermittent hypoxic training (IHT) on haematological values, aerobic capacity and performance in racing thoroughbreds. Abstract submitted to Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
305A Ergot alkaloids screened by electrospray[+] tandem MS/MS
305B Electrospray[+] tandem quadrupole mass spectrometry in the elucidation of ergot alkaloids chromatographed by HPLC: screening of grass or forage samples for novel toxic compounds.  J. Mass Spectrom. 2005; 40: 1484Ė1502
306 A simple, rapid and highly sensitive spectrophotometric method for determination of cyanide in equine biological samples. Toxicology Mechanisms and Methods 13:129-138, 2003. [KY Ag Exp Sta# 02-14-85]
307A The toxicokinetics of cyanide and mandelonitrile in the horse and their relevance to the Mare Reproductive Loss Syndrome.  Toxicology Mechanisms and Methods, 13:199-211, 2003. [KY Ag Exp Sta# 02-14-86]
307B The pharmacokinetics of cyanide and mandelonitrile in the horse and their relevance to the Mare Reproductive Loss Syndrome. Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #03-14-071]
308 The Kentucky 2001 mare reproductive loss syndrome (MRLS): overview and preliminary toxicological approaches
309 Final summary report: Identification of appropriate standards for corrective action for a release from petroleum underground storage tanks. Submitted to Petroleum Underground Storage Tank Environmental Assurance Fund Commission, 1995.  Sendlein LVA, Birge WJ, Blomquist GC, Dinger JS, Huffsey RR, Horstman SW, Kercher MD, McGinley P, Short DC, Struttman T, Taylor L, Tobin T, Dunn D, Naugle BI:
310 Determination of the Highest No-effect Dose (HNED) and of the elimination pattern for cocaine in horses. J Appl Toxicol 22:117-121, 2002. [KY Ag Exp Sta #02-14-156]
311 MRLS and Associated Syndromes: Toxicological Hypotheses (Tobin proposes septic setal emboli hypothesis). In Proc First 1st Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, p75.
312 Detection of selegiline and selegiline metabolites in an ELISA assay for amphetamine. Manuscript submitted to Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
313 ELISA assay for ketamine. Manuscript submitted to Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
314 ELISA assay for guanabenz. Manuscript submitted to Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
315 ELISA assay for apomorphine. Manuscript submitted to Proc 14th Intíl Conf Racing Ana≠lysts Vets, Orlando, FL, 2002.
316 Cherry trees, plant cyanogens, caterpillars and Mare Reproductive Loss Syndrome [MRLS]: Toxicological evaluation of a working hypothesis. In Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp68-74. [KY Ag Exp Sta # 02-14-167]
317 The detection, quantification and pharmacokinetics of furosemide and its effects on urinary specific gravity following intravenous administration to horses. Manuscript in press, Veterinary Therapeutics, 2003. [KY Ag. Exp. Sta. #03-14-104]
318 Blood plasma concentrations of insulin-like growth factor-1 (IGF-1) in resting standardbred horses. The Vet J 163:45-50, 2002.
319 Experimentally Induced Mare Reproductive Loss Syndrome [MRLS] Late Fetal Losses with Eastern Tent Caterpillars. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp80-81.
320 A laboratory animal model of Mare Reproductive Loss Syndrome [MRLS]: preliminary evaluation of a mouse model. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp51-53.
321 Effect of furosemide on urine specific gravity and osmolality in Thoroughbred racehorses. Veterinary Therapeutics, 4(3):292-298, 2003. [Ky Ag Exp Sta # 02-14-180]
322 Development of a method for the detection and confirmation of the "α2-agonist amitraz and its metabolites in horse urine. Manuscript accepted by J Anal Tox, 2003.
323 Septic Penetrating Setae/Septic Emboli/Septic Penetrating Setal Emboli (SPS/SE/SPSE): A hypothesis to explain the pathogenesis of the Mare Reproductive Loss Syndrome. Copyright registered at Library of Congress, June 17, 2003, #TXU1111484.
324A Metabolism of the beta-agonist ractopamine in the horse  
324B Detection and confirmation of ractopamine and its metabolites in horse urine after Payleanģ administration. J Anal Tox, 2004.    [KY Ag Exp Sta # 03-14-041]
325 The past and future of equine drug testing and medication regulation.  24th Bain-Fallon Lectures, 2002
326A Factors affecting "detection times" and "withdrawal times" for NSAIDS. 24th Bain-Fallon Lectures, 2002
326B The Mare Reproductive Loss Syndrome: an ongoing toxicological/other investigation. Submitted to Proc 24th Bain-Fallon Memorial Lectures, Gold Coast, Australia, 2002.
327 Pre-purchase, and drug testing of horses: a review. 24th Bain-Fallon Lectures, 2002
328 US Patent Application ó Guanabenz: a newly identified equine and veterinary sedative, tranquilizer, and analgesic
329 Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology. 15(5):934-40, 1992.
330 National Horsemenís Benevolent and Protective Association, Inc. Proposed National Policy on Drug Testing and Therapeutic Medication Regulation. J Eq Vet Sci 23(1): 4-5, 18-40, 2003. [Ky Ag Exp Sta# 03-14-072]  ---  Superceeded by 2012 book.
331 Mare Reproductive Loss Syndrome (MRLS) and the eastern tent catapillar: a toxicokinetic/statistical analysis with clinical, epidemiologic, and mechanical implications.  J Vet Therap 4(4):324-39, 2005.
332 Detection of selegiline and its major urinary metabolite, N-desmethylselegiline, in equine urine: A preliminary report. Submitted to Proceedings of the 54th Meeting of the Association of Official Racing Chemists, Lexington, KY, 2001.   [KY Ag Exp Sta #01-14-186]
333 Over≠view of dietary, environmental, and endogenous substances of regulatory concern in racing horses. Proc 41st Convent Am Assoc Equine Pract, Lexington, KY, 1995, pp156-159.
334 Test of time ó ELISA testing.  The Blood Horse, November 17, 1990, pp. 6188-6190.
335 An overview of the effective world rules on therapeutic medications ó Superceeded by the 2012 book.
336 Metabolism of the α2-agonist amitraz in horses and confirmation of its administration, Proc 15th Intl Conf Racing Analysts Vets, pp. 155-160 [KY Ag Exp Sta #04-14-010].
337 Metabolism of the beta-adrenergic agonist ractopamine in horses and confirmation of its administration with GC/MS. 15th Intl Conf Racing Analysts Vets, pp.93-98 [KY Ag Exp Sta #04-14-008]
338 A toxicokinetic/Accelerated Failure Time Analysis of the Mare Reproductive Loss Syndrome (MRLS). Proc 15th Intl Conf Racing Analysts Vets, 2004. p212-217 [KY Ag Exp Sta #04-14-020]
339 Septic Penetrating Setae/Bacteria/Bacterial Emboli/Septic Penetrating Setal Emboli (SPS/B/BE/SPSE): A hypothesis to explain the pathogenesis of Mare Reproductive Loss Syndrome [MRLS]. 15th Intl Conf Racing Analysts Vets, p. 418-422 , 2004.
340 Preliminary report on the confirmation and quantitative determination of salmeterol in equine urine. Proc 15th Intl Conf Racing Analysts Vets, 2004. p. 406-411[KY Ag Exp Sta #04-14-009]
341 Synthesis and certification of salmeterol and salmeterol-d12 standards. Proc 15th Intl Conf Racing Analysts Vets, 2004. p405
342 The mare reproductive loss syndrome (MRLS) and the eastern tent caterpillar II. A toxicokinetic/ clinical evaluation and proposed pathogenesis: septic penetrating setae.
343 US Patent 5,883,095 ó Formulations and methods to treat and prevent EPM óclazuril, diclazuril, toltrazuril
344 US Patent 4,473,640 ó Detection of morphine and its analogues using enzymatic hydrolysis with Ŗ-glucuronidase.
345 ELISA testing of racing horses. an overview.   (slide presentation)
346 Detection and identification of dizocilpine and its major urinary metabolites in the horse: a preliminary report. Chromatographia 59:S95-S103, 2004. [KY Ag Exp Sta #04-14-003]
347 Determination of salmeterol in equine urine and serum. Chromatographia 59:S79-S84, 2004. [KY Ag Exp Sta# 04-14-011]
348 Cyanide in the horse: Normal blood concentrations and their elevation, monitoring, and manipulation. (Abstract)
349 Number of negative tests required to exclude specified levels of agent abuse in equine forensic chemistry. Manuscript in progress, 2004.
350 Preparation and Chromatographic Characterization of tetrahydrogestrinone (THG), a New ďdesignerĒ Anabolic Steroid. Chromatographia, 60, 359-363. [KY Ag Exp Sta #04-14-052
351 Chromatographic detection of trimetoquinol (Inolinģ) and its major urinary metabolites in the horse: a preliminary report
352 US Patent for the control or eastern tent caterpillars
353 Preparation and analysis of tetrahydrogestrinone (THG), a recently reported ďdesignerĒ anabolic steroid. Proc 15th Intl Conf Racing Analysts Vets,.p518-522
353.5  Preparation and chromatographic characterization of tetrahydrogestrinone, a new "designer" anabolic steroid. Chromatographia.  2004, 60, 359Ė363
354 An overview of analytical/pharmacological relationships and the need for limitations on the sensitivity of testing for certain agents. Proc 12th Intíl Conf Racing Ana≠lysts Vets, Vancouver, Canada, 1998, pp210-216. [KY Ag Exp Sta #98-14-50]
355 Enzyme Linked Immunoassay Drug Testing (ELISA)   The Blood-Horse, Jan 1988
356 ELISA Testing.  The Blood-Horse, Sep 1988
357 Experiences as an expert witness ó 25 years since Hong Kong
358 Review of Environmental Morphine Identifications: World wide occurrences and Responses of Authorities.  AAEP Proc. vol. 61 p58-64
359 Drugs, Medications, and Performance Altering Substances: Their Performance Effects, Detection and Regulation: From 1800 to Keenland Oct 12th 2005
360 Intravenous and intratracheal administration of trimetoquinol, a fast-acting short-lived bronchodilator in horses with 'heaves'. Equine Vet J. 38(6):563-9
361 Analysis of prohibited substances in Kentucky with emphasis on strategies for practitioners to avoid problems. Proc 41st Convent Am Assoc Equine Pract, Lexington, KY, 1995, pp160-162.
362 Trimetoquinol: bronchodilator effects in horses with heaves following aerosolised and oral administration. Equine Vet J. 39(3):215-20
363 Caffeine and Theobromine Identifications in Post race Urines: Threshold Levels and Regulatory Significance of Such Identifications. AAEP Proc. Vol. 53 p87-92.
364 Plasma and urinary concentrations of trimetoquinol by LC-MS-MS following intravenous and intra-tracheal administration to horses with heaves. J Vet Pharmacol Ther 31(6):501-10
365 Gabapentin in horses: validation of an analytical method for gabapentin quantitation. J Anal Toxicol. 31(9):555-65
366 ESI+MS/MS confirmation of canine ivermectin toxicity.  J Mass Spectrom.44(1):1119.
367 Pharmacokinetics of gabapentin in horses. J Vet Pharmacol Ther. 31(2):175-7, 2008
368 Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry. Journal of Chromatography B 829 56Ė68.
369 Review of the Current Status of Thresholds/Withdrawal Time Guidelines for Therapeutic Medications in Performance Horses. AAEP proc. Vol.54 p29-37
370 Nonsteroidal anti-inflammatory agents and musculoskeletal injuries in Thoroughbred racehorses in Kentucky J. vet. Pharmacol. Therap. doi: 10.1111/j.1365-2885.2008.01038.x
371 Synthesis of deuterated analytical standards: Ketoprofen-d3 and Flunixin-d3. Proceedings of the 16th International Conference of Racing Analysts and Veterinarians, Tokyo, Japan, pp214-217
372 New therapeutic approaches to equine protozoal myeloencephalitis: Clinical pharmacology and apparent efficacy of diclazuril, toltrazuril and sulfonotoltrazuril. Submitted to J Vet Pharmacol Therap, 2001. [KY Ag. Exp. Sta #00-14-102]
373 Pyrilamine in the horse: Detection and pharmacokinetics of pyrilamine and its major urinary metabolite ďO-desmethylpyrilamineĒ. J Vet Pharmacol Ther. 2009 Feb;32(1):66-78
374 Serum concentrations of ergovaline/ ergot alkaloids in late-term pregnant mares grazing entophyte infected tall fescue pastures: A preliminary  report.  Theriogenology 70 (2008) p583
375 Serum concentrations of ergovaline and ergot alkaloids in horses grazing entophyte positive pastures
376A Corrupt Horseracing Practices ó 1983 US House Hearing.  Part 1
376B Corrupt Horseracing Practices ó 1983 US House Hearing.  Part 2
377 Short Communication: A rapid and sensitive Enzyme Linked ImmunoSorbent Assay (ELISA) test for guanabenz in the horse. Manuscript in preparation, 2003.
378 National HBPA Medication Policy Document, October 2001 ó Superceeded by 2012 book.
379 Tramadol in the Horse: A Preliminary Report on its Detection, Pharmacokinetics and Pharmacodynamics Responses. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey, pp 106-115.
380 Intravenous Tramadol: Effects, Nociceptive Properties, and Pharmacokinetics in Horses. Veterinary Anaesthesia and Analgesia 36, 581-590.
381 Synthesis and Detection Of Toltrazuril Sulfone and Its Pharmacokinetics In Horses Following Administration In Dimethylsulfoxide. J Vet Pharmacol Ther. 2009 Aug; 32(4):368-78
382 Pemoline and Tetramisole ďPositivesĒ In English Racehorses Following Levamisole Administration.  Irish Vet J   63(8):498-500, 2010
383 Effect of Dimethylsulphoxide (DMSO) On Oral bioavailability Of a Triazine Based Antiprotozoalagent Toltrazuril Sulfone In The Horse. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey. pp.315-320
384 Nonsteroidal Anti-Inflammatory (NSAID) Agents And Musculoskeletal Injuries In Thoroughbred Racehorses In Kentucky. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey. pp 329-333
385 Cůmo evitar resultados positivos en el doping: las reglas de la via terapťutica.  3rd Congreso Mundial Equino Confepaso
386 Certified Reference Standards and Stable Isotope Internal Standards for Equine Therapeutic Medication Regulation. In press, Proceedings of the 18th International Conference of Racing Analysts and Veterinarians,Queens Town, New Zealand
387 Clinically effective loading dose schedule for Ponazurilģ in the horse
388 ďShipping InĒ A Risk Factor Associated with Fatal Musculoskeletal Racing Injuries. Submitted for publication, 
389 Evaluation of mass spectrometric methods for detection of the anti-protozal drug imidocarb. Journal of Analytical Toxicology 35:199-204, 2011
390 Race for the Prize -- interview with Thomas Tobin in The Irish Vet Journal. Aug 2010
391

The mare reproductive loss syndrome and the eastern tent caterpillar II: a toxicokinetic/clinical evaluation and a proposed pathogenesis: spetic penetrating setae.  Int. J. Appl. Res. Vet. Med., 2 (2004), pp. 142Ė158

392 Polymorphism in 2-(4-hydroxy-2,6-dimethylanilino)-5,6-dihydro-4H-1,3-thiazin-3-ium chloride. Acta Crystallographica Sec. C: Crystal Structure Communications  C66:o595-96, 2011
393 Equine protozoal myeloencephalitis (EPM): causative agents, clinical signs, current therepeutic approaches
394 Solvatomorphism in (E)-2-(2,6-di-chloro-4-hydroxybenzylidene)-hydrazinecarboximidamide. Acta Chrystallographica C67:o310-14, 2011
395 Diclazuril protects against maternal gastrointestinal syndrome and congenital toxoplasmosis. Int J Clin Med, 2014, 5:93-101
396 ESI-Mass spectrometric and HPLC elucidation of a new ergot alkaloid from perennial ryegrass hay silage associated with bovine reproductive problems, In press, Toxicology Mechanisms and Methods, 2011 KAES Article # 11-14-031 UK # 396.
397 Toltrazuril sulfone: synthesis, detection, and pharmacokinetics in the horse.  J Vet Pharmacol Therap
398 Synthesis of myo-inositol trispyrophosphate (ITPP)  for use as an analytical standard.  Proceedings 19th International Conference of Racing Analysts and Veterinarians, Philadelphia, Pennsylvania, September 15-22, 2012
399 Furosemide, the Prevention of Epistaxis and Related Considerations: A Preliminary Evaluation:.  Intern J Appl Res Vet Med. Vol 10(2), 2012. pp176-185.
400 Foreign substances reported in Iowa racing, 2001 Ė 2011: a review and analysis, Submitted for presentation and  publication, American Association of Equine Practitioners Annual Convention, Anaheim, CA.  December 3. 2012.
401 Cathinone and related "Bath Salt" substances ó detection in equine urine and potential sources.  Proceedings 19th International Conference of Racing Analysts and Veterinarians. Philadelphia, Pennsylvania, September 15-22, 2012
402 Synthesis of 3-hydroxymepivacaine-d3 as an internal standard for equine medication regulation.  Proceedings 19th International Conference of Racing Analysts and Veterinarians. Philadelphia, Pennsylvania, September 15-22, 2012
403 A clinicians guide to factors affecting withdrawal times for equine therapeutic medications.  The Veterinary Journal.  2013
404 Furosemide, Epistaxis and the Racing Horse: A review and Analysis: in progress, invited review for The Veterinary Journal
405 Atovaquone ameliorated gastrointestinal toxoplasmosis complications in a pregnancy model.  Med Sci Monit 18(9):BR337-45
406 A toxicogy and clinical study of post race epistaxis associated with exercise induced pulmonary hemorrhage (EIPH) in Thoroughbred race horses a the Racecourse Rinconada, Caracas, Venezuela.   1:348. doi:10.4172/scientificreports.348
407 Current therapeutic approaches to equine protozoal myeloencephalitis.  J Am Vet Med Assoc. 2013, Vol. 242, No. 4,  pp 482-91
408 Bovine Colostrum supplementation does not influence serum IGF-1 in horses in race training, Submitted March 2013 for publication in The Veterinary Journal.
409 Bovine Colostrum supplementation decreases the incidence of upper respiratory infection in horses in race training and may improve performance and recovery; Submitted for presentation and publication, Proceedings of the 59th AAEP Annual Convention, Nashville, Tennessee December 2013, 
410 An overview of the effective world rules on therapeutic medications. Booklet published by Gluck Equine Research Center.  ó Superceeded by 2012 book.
411 Iron - its functions and metabolism in the horse. Equine Sports Med News 1984 4(2):1-3
412 World Rules for Equine Drug Testing and Therapeutic Medication Regulation; 2012 Policy of the National Horsemen's Benevolent and Protective Association, Inc.   Wind Publications, 600 Overbrook Dr, Nicholasville, KY 40356, USA pp 370  KAES Article # 11-014-096 
413 Synthesis, purification, chemical characterization of 20-dihydro-6-methylprednisone, an isomeric metabolite of methylprednisolone in the horse.  Drug Testing and Analysis 6(3):303Ė07March 2014
414 Diclazuril: safe and highly effective fetal protection in a mouse model of fetal/congenital toxoplasmosis
415 Scopolamine in racing horses: trace identifications associated with dietary or environmental exposure. A review.  The Veterinary Journal.
416 Sudden death in the Throughbred horse at Racetrack La Rinconada, Caracas-Venezeula. Presented at the Congreso Internacional de Medicina y CirugŪa Equina 2013: Muerte Subita en  Caballos Pura Sangre Ingles Decarrera Hipodromo ďLa RinconadaĒ Caracas-Venezeula.  

417

The mare reproductive loss syndrome (MRLS) and the eastern tent caterpillar: immunological testing of aborting mares.   Intern J Appl Res Vet Med.   2005, 3(3):207-216
418

Deteccion de Furosemida y Otras Substancias en Caballos de Carrera. (Detection of furosemide and other substances in race horses)  Presented at 5th Simpůsio da AssociaÁ„o Latinoamericana de Patologia Toxicolůgica, 13 April 2014, S„o Paulo, Spain.

419 Cobalt use and regulation in horse racing: A review.   (submitted for publication)
420 Increased incidence of sudden death associated with exercise induced pulmonary hemorrhage (EIPH) in horses racing at higher altitude in Venezuela.  Proceedings of the 20th Int Conf of Racing Analysts and Veterinarians. 2014.
421 20-Dihydro-6-methylprednisone, an isomeric metabolite of methylprednisolone: synthesis of an analytical standard  Proceedings of the 20th Int Conf of Racing Analysts and Veterinarians. 2014.
422 Dihydoprednisone, an isomeric metabolite of prednisolone: synthesis of an analytical standard  Proceedings of the 20th Int Conf of Racing Analysts and Veterinarians. 2014.

423

Tramadol: A human therapeutic medication and an environmental substance occasionally identified in equine drug testing. Submitted to The Veterinary Journal

424

An unusual cluster of low concentration methamphetamine identifications in racing horses associated with a methamphetamine-contaminated horse trailer: a report and analysis                 (submitted for publication)